Amarin Corp Plc (AMRN)

[sts66]

There's justified skepticism the FDA will not work with Amarin to ever approve another label for Vascepa ever. This is directly based on the actions the FDA has taken in the past.

And it doesn't help our cause or the pps when AMRN specifically points that out in a CC as rationale for shelving development of AMR-102, essentially saying "we don't trust the FDA".